Related Experiment Video

Updated: Jul 18, 2025

Characterizing Extracellular Vesicles from Biological Fluids
05:07

Characterizing Extracellular Vesicles from Biological Fluids

Published on: February 28, 2025

427

Extracellular Vesicles and Hypertension

Heng Tang1, Yuxue Hu2, Jiali Deng3

  • 1Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Advances in Experimental Medicine and Biology
|August 21, 2023
PubMed

Insights

Extracellular vesicles are linked to hypertension development and progression. These vesicles show potential as diagnostic and prognostic biomarkers for hypertension, requiring further large-scale studies.

Area of Science:

  • Cardiovascular Research
  • Biomarker Discovery
  • Cellular Biology

Background:

  • Hypertension is a major global health issue, causing significant cardiovascular disease and mortality.
  • Extracellular vesicles (EVs) mediate intercellular communication, transferring molecules like proteins, lipids, and nucleic acids.
  • EVs play roles in both normal physiological processes and disease pathogenesis.

Purpose of the Study:

  • To review the role of extracellular vesicles in the pathogenesis of essential and secondary hypertension.
  • To explore the potential of extracellular vesicles as biomarkers for hypertension diagnosis, treatment, and prognosis.

Main Methods:

  • Literature review and synthesis of existing research on extracellular vesicles and hypertension.
  • Analysis of studies investigating EV involvement in renin-angiotensin-aldosterone system and vascular cell crosstalk.
  • Examination of EV roles in secondary hypertension etiologies.

Main Results:

  • Extracellular vesicles are implicated in essential hypertension by modulating the renin-angiotensin-aldosterone system and intercellular communication.
  • EVs contribute to the pathogenesis of various secondary hypertension types, including kidney diseases and endocrine disorders.
  • Extracellular vesicles demonstrate promise as novel biomarkers for hypertension management.

Conclusions:

  • Extracellular vesicles are key players in hypertension development and progression.
  • EVs hold significant potential as diagnostic and prognostic biomarkers for hypertension.
  • Further large-scale, multicenter studies are needed to validate EV biomarker sensitivity and specificity.

Keywords:
Extracellular vesiclesHypertensionRenin–angiotensin–aldosterone systemSecondary hypertensionVascular cells

More Related Videos

Evaluation of the Storage Stability of Extracellular Vesicles11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

14.2K
Uptake of Fluorescent Labeled Small Extracellular Vesicles In Vitro and in Spinal Cord09:01

Uptake of Fluorescent Labeled Small Extracellular Vesicles In Vitro and in Spinal Cord

Published on: May 23, 2021

3.7K

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
15
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.7K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.6K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
690